Live

Watch CBS News

Nasal vaccine for Alzheimer's disease to begin human trials at Boston hospital

After 20 years of studies, researchers will begin the first human trial for a nasal vaccine aimed at preventing and slowing Alzheimer's disease. Sixteen participants at Boston's Brigham and Women's Hospital will receive two doses of the vaccine one week apart. CBS Boston's Zinnia Maldonado has more.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.